Thalio Tablets (Talniflumeate)

Adult dose

Administer 370 mg orally 3 times daily as talniflumate. For severe cases, administer 740 mg per dose. Adjust the dose appropriately according to age and symptoms.

This medication can cause gastrointestinal bleeding in individuals who regularly consume more than three glasses of alcohol daily; therefore, it should be discussed with a doctor or pharmacist. This medication may increase the risk of cardiovascular disease; patients with a history of heart disease or stroke, or those with risk factors, should exercise extra caution. This medication can cause severe gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, with an increased risk in elderly patients. Patients with a history of peptic ulcers or allergies to any of the ingredients of this medication, and those with severe diseases of the heart, liver, kidneys, pregnant or breastfeeding women should not take this medication. Patients with slightly impaired liver or kidney function, elderly patients, and those taking diuretics should use this medication with caution. While taking this medication, symptoms such as nausea, vomiting, diarrhea, abdominal pain, skin rash, and respiratory distress may occur as allergic reactions or serious side effects; therefore, if there are any unusual symptoms, immediate medical advice should be sought. This medication may increase blood pressure or worsen heart failure, so patients with hypertension or heart failure should regularly monitor their condition. Regular liver and kidney function tests should be performed during long-term use, and administration may be halted in the event of abnormal findings. It is advisable to avoid concurrent use with other anti-inflammatory pain relievers and to be cautious of interactions when used in combination with specific diuretics, anticoagulants, lithium, and methotrexate. During pregnancy, particularly in the late stages, it may pose risks to the fetus, so women of childbearing potential or those who are pregnant should not take it, and nursing mothers should either stop breastfeeding or discontinue the medication. This medication should not be administered to children under 12 years of age, and elderly patients should be given the lowest effective dose with caution. This medication should be stored out of reach of children and should not be transferred to another container.

• Gastrointestinal bleeding
• cardiovascular thrombosis reaction
• myocardial infarction
• stroke
• nausea
• vomiting
• photosensitivity
• asthma attacks
• generalized weakness due to hypotension
• hypersensitivity shock

This medication should be stored in a sealed container to prevent the ingress of air and moisture and should preferably be kept at a temperature between 1°C and 30°C. By doing so, the efficacy of the medication will be maintained and it can be used safely.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle